Found 8 matching trials
LMB-2 Immunotoxin in Treating Young Patients With Relapsed or Refractory Leukemia or Lymphoma
PHASE1RATIONALE: LMB-2 immunotoxin can locate cancer cells and kill them without ...
Location
Winship Cancer Institute of Emory University
LMB-2 to Treat Hairy Cell Leukemia
PHASE2Background:
* About 80% of patients with hairy cell leukemia (HCL) have tu...
Location
National Institutes of Health Clinical Center, 9000 Rockville Pike
Immunotoxin in Treating Patients With Leukemia or Lymphoma
PHASE1RATIONALE: Immunotoxins can locate cancer cells and either kill them or del...
Location
Laboratory of Molecular Biology
Phase II Trial of LMB-2, Fludarabine and Cyclophosphamide for Adult T-Cell Leukemia
PHASE1BACKGROUND:
* Cluster of differentiation 25 (CD25) (p55, Tac or interleuki...
Location
National Institutes of Health Clinical Center, 9000 Rockville Pike
Anti-Tac(Fv)-PE38 (LMB-2) to Treat Cutaneous T-Cell Lymphomas
PHASE2This study will evaluate the effectiveness of an experimental drug called L...
Location
National Institutes of Health Clinical Center, 9000 Rockville Pike
Fludarabine and Cyclophosphamide Followed By LMB-2 Immunotoxin in Treating Patients With Hodgkin's Lymphoma
NARATIONALE: Drugs used in chemotherapy, such as fludarabine and cyclophospha...
Location
Warren Grant Magnuson Clinical Center - NCI Clinical Trials Referral Office
Anti-Tac(Fv)-PE38 (LMB-2) to Treat Chronic Lymphocytic Leukemia
PHASE2This study will evaluate the effectiveness of an experimental drug called L...
Location
National Institutes of Health Clinical Center, 9000 Rockville Pike
LMB-2 Immunotoxin and Vaccine Therapy in Treating Patients With Metastatic Melanoma That Cannot Be Removed By Surgery
PHASE2RATIONALE: The LMB-2 immunotoxin can find tumor cells and kill them without...
Location
Warren Grant Magnuson Clinical Center - NCI Clinical Trials Referral Office